The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell Line Engineering Services Market Research Report 2024

Global Cell Line Engineering Services Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1745673

No of Pages : 99

Synopsis
Cell line engineering services is a biotechnology service that utilizes gene editing and cell culture technologies to edit and modify cells for various research and application needs. In this service, professional scientists design suitable gene editing schemes based on the customer's requirements and use gene editing tools such as CRISPR/Cas9 to precisely modify, insert, or delete the target gene sequence. Through specific cell culture techniques, the modified cells can obtain superior phenotypes and characteristics, such as higher product yield, better growth characteristics, and higher immune response.

Cell line engineering services are mainly applied in the field of biomedicine, such as drug screening, immunotherapy, gene therapy, etc. Furthermore, since this technology can be applied to various types of cells and animal and plant cells, it can also be applied in fields such as food and agriculture, such as improving the disease resistance of some plants and improving the quality of certain meat products.

Global Cell Line Engineering Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Line Engineering Services market research.

Key companies engaged in the Cell Line Engineering Services industry include CD BioSciences, Curia, Horizo​​n Discovery, Multispan, Inc., System Biosciences (SBI), Biocon, Cyagen, Analytical Biological Services (ABS) and Celvab, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Cell Line Engineering Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell Line Engineering Services market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cell Line Engineering Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • CD BioSciences
  • Curia
  • Horizo​​n Discovery
  • Multispan, Inc.
  • System Biosciences (SBI)
  • Biocon
  • Cyagen
  • Analytical Biological Services (ABS)
  • Celvab
  • Boston Institute of Biotechnology
  • ALSTEM
  • ProMab Biotechnologies
  • Cytosurge AG
  • Merck
  • Thermo Fisher Scientific
  • WuXi Advanced Therapies
  • GenScript Biotech Corporation (HK.1548)

Segment by Type

  • Small scale
  • Medium scale
  • Large scale

Segment by Application

  • Bio-pharmaceutical
  • Medical Treatment
  • Medical Research
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Cell Line Engineering Services report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line Engineering Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small scale
1.2.3 Medium scale
1.2.4 Large scale
1.3 Market by Application
1.3.1 Global Cell Line Engineering Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Bio-pharmaceutical
1.3.3 Medical Treatment
1.3.4 Medical Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line Engineering Services Market Perspective (2018-2029)
2.2 Cell Line Engineering Services Growth Trends by Region
2.2.1 Global Cell Line Engineering Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Line Engineering Services Historic Market Size by Region (2018-2023)
2.2.3 Cell Line Engineering Services Forecasted Market Size by Region (2024-2029)
2.3 Cell Line Engineering Services Market Dynamics
2.3.1 Cell Line Engineering Services Industry Trends
2.3.2 Cell Line Engineering Services Market Drivers
2.3.3 Cell Line Engineering Services Market Challenges
2.3.4 Cell Line Engineering Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line Engineering Services Players by Revenue
3.1.1 Global Top Cell Line Engineering Services Players by Revenue (2018-2023)
3.1.2 Global Cell Line Engineering Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell Line Engineering Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Line Engineering Services Revenue
3.4 Global Cell Line Engineering Services Market Concentration Ratio
3.4.1 Global Cell Line Engineering Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line Engineering Services Revenue in 2022
3.5 Cell Line Engineering Services Key Players Head office and Area Served
3.6 Key Players Cell Line Engineering Services Product Solution and Service
3.7 Date of Enter into Cell Line Engineering Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line Engineering Services Breakdown Data by Type
4.1 Global Cell Line Engineering Services Historic Market Size by Type (2018-2023)
4.2 Global Cell Line Engineering Services Forecasted Market Size by Type (2024-2029)
5 Cell Line Engineering Services Breakdown Data by Application
5.1 Global Cell Line Engineering Services Historic Market Size by Application (2018-2023)
5.2 Global Cell Line Engineering Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Line Engineering Services Market Size (2018-2029)
6.2 North America Cell Line Engineering Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Line Engineering Services Market Size by Country (2018-2023)
6.4 North America Cell Line Engineering Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line Engineering Services Market Size (2018-2029)
7.2 Europe Cell Line Engineering Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Line Engineering Services Market Size by Country (2018-2023)
7.4 Europe Cell Line Engineering Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Engineering Services Market Size (2018-2029)
8.2 Asia-Pacific Cell Line Engineering Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Line Engineering Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Line Engineering Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line Engineering Services Market Size (2018-2029)
9.2 Latin America Cell Line Engineering Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Line Engineering Services Market Size by Country (2018-2023)
9.4 Latin America Cell Line Engineering Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Engineering Services Market Size (2018-2029)
10.2 Middle East & Africa Cell Line Engineering Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Line Engineering Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Line Engineering Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD BioSciences
11.1.1 CD BioSciences Company Detail
11.1.2 CD BioSciences Business Overview
11.1.3 CD BioSciences Cell Line Engineering Services Introduction
11.1.4 CD BioSciences Revenue in Cell Line Engineering Services Business (2018-2023)
11.1.5 CD BioSciences Recent Development
11.2 Curia
11.2.1 Curia Company Detail
11.2.2 Curia Business Overview
11.2.3 Curia Cell Line Engineering Services Introduction
11.2.4 Curia Revenue in Cell Line Engineering Services Business (2018-2023)
11.2.5 Curia Recent Development
11.3 Horizo​​n Discovery
11.3.1 Horizo​​n Discovery Company Detail
11.3.2 Horizo​​n Discovery Business Overview
11.3.3 Horizo​​n Discovery Cell Line Engineering Services Introduction
11.3.4 Horizo​​n Discovery Revenue in Cell Line Engineering Services Business (2018-2023)
11.3.5 Horizo​​n Discovery Recent Development
11.4 Multispan, Inc.
11.4.1 Multispan, Inc. Company Detail
11.4.2 Multispan, Inc. Business Overview
11.4.3 Multispan, Inc. Cell Line Engineering Services Introduction
11.4.4 Multispan, Inc. Revenue in Cell Line Engineering Services Business (2018-2023)
11.4.5 Multispan, Inc. Recent Development
11.5 System Biosciences (SBI)
11.5.1 System Biosciences (SBI) Company Detail
11.5.2 System Biosciences (SBI) Business Overview
11.5.3 System Biosciences (SBI) Cell Line Engineering Services Introduction
11.5.4 System Biosciences (SBI) Revenue in Cell Line Engineering Services Business (2018-2023)
11.5.5 System Biosciences (SBI) Recent Development
11.6 Biocon
11.6.1 Biocon Company Detail
11.6.2 Biocon Business Overview
11.6.3 Biocon Cell Line Engineering Services Introduction
11.6.4 Biocon Revenue in Cell Line Engineering Services Business (2018-2023)
11.6.5 Biocon Recent Development
11.7 Cyagen
11.7.1 Cyagen Company Detail
11.7.2 Cyagen Business Overview
11.7.3 Cyagen Cell Line Engineering Services Introduction
11.7.4 Cyagen Revenue in Cell Line Engineering Services Business (2018-2023)
11.7.5 Cyagen Recent Development
11.8 Analytical Biological Services (ABS)
11.8.1 Analytical Biological Services (ABS) Company Detail
11.8.2 Analytical Biological Services (ABS) Business Overview
11.8.3 Analytical Biological Services (ABS) Cell Line Engineering Services Introduction
11.8.4 Analytical Biological Services (ABS) Revenue in Cell Line Engineering Services Business (2018-2023)
11.8.5 Analytical Biological Services (ABS) Recent Development
11.9 Celvab
11.9.1 Celvab Company Detail
11.9.2 Celvab Business Overview
11.9.3 Celvab Cell Line Engineering Services Introduction
11.9.4 Celvab Revenue in Cell Line Engineering Services Business (2018-2023)
11.9.5 Celvab Recent Development
11.10 Boston Institute of Biotechnology
11.10.1 Boston Institute of Biotechnology Company Detail
11.10.2 Boston Institute of Biotechnology Business Overview
11.10.3 Boston Institute of Biotechnology Cell Line Engineering Services Introduction
11.10.4 Boston Institute of Biotechnology Revenue in Cell Line Engineering Services Business (2018-2023)
11.10.5 Boston Institute of Biotechnology Recent Development
11.11 ALSTEM
11.11.1 ALSTEM Company Detail
11.11.2 ALSTEM Business Overview
11.11.3 ALSTEM Cell Line Engineering Services Introduction
11.11.4 ALSTEM Revenue in Cell Line Engineering Services Business (2018-2023)
11.11.5 ALSTEM Recent Development
11.12 ProMab Biotechnologies
11.12.1 ProMab Biotechnologies Company Detail
11.12.2 ProMab Biotechnologies Business Overview
11.12.3 ProMab Biotechnologies Cell Line Engineering Services Introduction
11.12.4 ProMab Biotechnologies Revenue in Cell Line Engineering Services Business (2018-2023)
11.12.5 ProMab Biotechnologies Recent Development
11.13 Cytosurge AG
11.13.1 Cytosurge AG Company Detail
11.13.2 Cytosurge AG Business Overview
11.13.3 Cytosurge AG Cell Line Engineering Services Introduction
11.13.4 Cytosurge AG Revenue in Cell Line Engineering Services Business (2018-2023)
11.13.5 Cytosurge AG Recent Development
11.14 Merck
11.14.1 Merck Company Detail
11.14.2 Merck Business Overview
11.14.3 Merck Cell Line Engineering Services Introduction
11.14.4 Merck Revenue in Cell Line Engineering Services Business (2018-2023)
11.14.5 Merck Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Line Engineering Services Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Line Engineering Services Business (2018-2023)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 WuXi Advanced Therapies
11.16.1 WuXi Advanced Therapies Company Detail
11.16.2 WuXi Advanced Therapies Business Overview
11.16.3 WuXi Advanced Therapies Cell Line Engineering Services Introduction
11.16.4 WuXi Advanced Therapies Revenue in Cell Line Engineering Services Business (2018-2023)
11.16.5 WuXi Advanced Therapies Recent Development
11.17 GenScript Biotech Corporation (HK.1548)
11.17.1 GenScript Biotech Corporation (HK.1548) Company Detail
11.17.2 GenScript Biotech Corporation (HK.1548) Business Overview
11.17.3 GenScript Biotech Corporation (HK.1548) Cell Line Engineering Services Introduction
11.17.4 GenScript Biotech Corporation (HK.1548) Revenue in Cell Line Engineering Services Business (2018-2023)
11.17.5 GenScript Biotech Corporation (HK.1548) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’